APA (7th ed.) Citation

AP, K., SC, S., J, S., U, M., VP, V., D, S., . . . S, P. (2022). Reviewing the potential application of miR-21 inhibitors in oral cancer therapeutics. Oral oncology, 125, 105713. https://doi.org/10.1016/j.oraloncology.2022.105713

Chicago Style (17th ed.) Citation

AP, K., Selvakumar SC, Selvaraj J, Mony U, Veeraraghavan VP, Sekar D, Govindarajan S, Raj AT, and Patil S. "Reviewing the Potential Application of MiR-21 Inhibitors in Oral Cancer Therapeutics." Oral Oncology 125 (2022): 105713. https://doi.org/10.1016/j.oraloncology.2022.105713.

MLA (9th ed.) Citation

AP, K., et al. "Reviewing the Potential Application of MiR-21 Inhibitors in Oral Cancer Therapeutics." Oral Oncology, vol. 125, 2022, p. 105713, https://doi.org/10.1016/j.oraloncology.2022.105713.